Fatal bleeding rare with extended dual antiplatelet therapy

Fatal bleeding is rare with extended dual antiplatelet therapy, according to a secondary analysis of the DAPT Study. Bleeding-related mortality accounted for a minority of deaths in patients treated with dual antiplatelet therapy beyond one year. —> Read More

facebooktwittergoogle_plusredditpinterestlinkedinmail